Inhaled corticosteroids and incident pneumonia in patients with asthma: Systematic review and meta-analysis

Vikas Bansal, Muhammad A. Mangi, Margaret Johnson, Emir Festic

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

OBJECTIVES: To systematically review all available studies on inhaled corticosteroid use and incident pneumonia in asthma patients.

METHODS: We performed a literature search from January 1, 1993, through August 15, 2015, using PubMed, Medline, CENTRAL, EMBASE, Scopus, ISI, Regulatory Documents, Web of Science and manufacturers' web clinical trial registries with multiple search terms. We included studies that compared the risk of incident pneumonia among patients utilizing and not utilizing inhaled corticosteroids. We then summarized risk estimates into two random-effect meta-analyses; one including randomized controlled trials and another one including observational studies.

RESULTS: Fourteen studies were estimable; ten randomized controlled trials included 19,098 participants and four observational studies included 44,016 participants. There was no heterogeneity in randomized trials and summed risk ratio demonstrated the use of inhaled corticosteroids was protective of pneumonia; risk ratio 0.74, 95% CI 0.57 to 0.95, p=0.02. On the contrary, observational studies showed summed odds ratio of 1.97; 95% CI 1.87 to 2.07, p<0.0001, I²=0%, suggesting increased risk of pneumonia with use of inhaled corticosteroids in asthma patients.

CONCLUSIONS: Inhaled corticosteroids are associated with decreased risk of incident pneumonia in patients with asthma based on meta-analysis of available randomized trials. Although observational studies in similar patients suggested higher risk of pneumonia, the inherent methodological limitations confer lower grade of confidence in these studies.

Original languageEnglish (US)
Pages (from-to)135-158
Number of pages24
JournalActa medica academica
Volume44
Issue number2
DOIs
StatePublished - 2015

Fingerprint

Meta-Analysis
Pneumonia
Adrenal Cortex Hormones
Asthma
Observational Studies
Odds Ratio
Randomized Controlled Trials
PubMed
Registries
Clinical Trials

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Inhaled corticosteroids and incident pneumonia in patients with asthma : Systematic review and meta-analysis. / Bansal, Vikas; Mangi, Muhammad A.; Johnson, Margaret; Festic, Emir.

In: Acta medica academica, Vol. 44, No. 2, 2015, p. 135-158.

Research output: Contribution to journalArticle

@article{fd62d25c854742e1a28937b4b080636b,
title = "Inhaled corticosteroids and incident pneumonia in patients with asthma: Systematic review and meta-analysis",
abstract = "OBJECTIVES: To systematically review all available studies on inhaled corticosteroid use and incident pneumonia in asthma patients.METHODS: We performed a literature search from January 1, 1993, through August 15, 2015, using PubMed, Medline, CENTRAL, EMBASE, Scopus, ISI, Regulatory Documents, Web of Science and manufacturers' web clinical trial registries with multiple search terms. We included studies that compared the risk of incident pneumonia among patients utilizing and not utilizing inhaled corticosteroids. We then summarized risk estimates into two random-effect meta-analyses; one including randomized controlled trials and another one including observational studies.RESULTS: Fourteen studies were estimable; ten randomized controlled trials included 19,098 participants and four observational studies included 44,016 participants. There was no heterogeneity in randomized trials and summed risk ratio demonstrated the use of inhaled corticosteroids was protective of pneumonia; risk ratio 0.74, 95{\%} CI 0.57 to 0.95, p=0.02. On the contrary, observational studies showed summed odds ratio of 1.97; 95{\%} CI 1.87 to 2.07, p<0.0001, I²=0{\%}, suggesting increased risk of pneumonia with use of inhaled corticosteroids in asthma patients.CONCLUSIONS: Inhaled corticosteroids are associated with decreased risk of incident pneumonia in patients with asthma based on meta-analysis of available randomized trials. Although observational studies in similar patients suggested higher risk of pneumonia, the inherent methodological limitations confer lower grade of confidence in these studies.",
author = "Vikas Bansal and Mangi, {Muhammad A.} and Margaret Johnson and Emir Festic",
year = "2015",
doi = "10.5644/ama2006-124.141",
language = "English (US)",
volume = "44",
pages = "135--158",
journal = "Acta medica academica",
issn = "1840-1848",
publisher = "Academy of Sciences and Arts of Bosnia and Herzegovina",
number = "2",

}

TY - JOUR

T1 - Inhaled corticosteroids and incident pneumonia in patients with asthma

T2 - Systematic review and meta-analysis

AU - Bansal, Vikas

AU - Mangi, Muhammad A.

AU - Johnson, Margaret

AU - Festic, Emir

PY - 2015

Y1 - 2015

N2 - OBJECTIVES: To systematically review all available studies on inhaled corticosteroid use and incident pneumonia in asthma patients.METHODS: We performed a literature search from January 1, 1993, through August 15, 2015, using PubMed, Medline, CENTRAL, EMBASE, Scopus, ISI, Regulatory Documents, Web of Science and manufacturers' web clinical trial registries with multiple search terms. We included studies that compared the risk of incident pneumonia among patients utilizing and not utilizing inhaled corticosteroids. We then summarized risk estimates into two random-effect meta-analyses; one including randomized controlled trials and another one including observational studies.RESULTS: Fourteen studies were estimable; ten randomized controlled trials included 19,098 participants and four observational studies included 44,016 participants. There was no heterogeneity in randomized trials and summed risk ratio demonstrated the use of inhaled corticosteroids was protective of pneumonia; risk ratio 0.74, 95% CI 0.57 to 0.95, p=0.02. On the contrary, observational studies showed summed odds ratio of 1.97; 95% CI 1.87 to 2.07, p<0.0001, I²=0%, suggesting increased risk of pneumonia with use of inhaled corticosteroids in asthma patients.CONCLUSIONS: Inhaled corticosteroids are associated with decreased risk of incident pneumonia in patients with asthma based on meta-analysis of available randomized trials. Although observational studies in similar patients suggested higher risk of pneumonia, the inherent methodological limitations confer lower grade of confidence in these studies.

AB - OBJECTIVES: To systematically review all available studies on inhaled corticosteroid use and incident pneumonia in asthma patients.METHODS: We performed a literature search from January 1, 1993, through August 15, 2015, using PubMed, Medline, CENTRAL, EMBASE, Scopus, ISI, Regulatory Documents, Web of Science and manufacturers' web clinical trial registries with multiple search terms. We included studies that compared the risk of incident pneumonia among patients utilizing and not utilizing inhaled corticosteroids. We then summarized risk estimates into two random-effect meta-analyses; one including randomized controlled trials and another one including observational studies.RESULTS: Fourteen studies were estimable; ten randomized controlled trials included 19,098 participants and four observational studies included 44,016 participants. There was no heterogeneity in randomized trials and summed risk ratio demonstrated the use of inhaled corticosteroids was protective of pneumonia; risk ratio 0.74, 95% CI 0.57 to 0.95, p=0.02. On the contrary, observational studies showed summed odds ratio of 1.97; 95% CI 1.87 to 2.07, p<0.0001, I²=0%, suggesting increased risk of pneumonia with use of inhaled corticosteroids in asthma patients.CONCLUSIONS: Inhaled corticosteroids are associated with decreased risk of incident pneumonia in patients with asthma based on meta-analysis of available randomized trials. Although observational studies in similar patients suggested higher risk of pneumonia, the inherent methodological limitations confer lower grade of confidence in these studies.

UR - http://www.scopus.com/inward/record.url?scp=84988864342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988864342&partnerID=8YFLogxK

U2 - 10.5644/ama2006-124.141

DO - 10.5644/ama2006-124.141

M3 - Article

C2 - 26702909

AN - SCOPUS:84988864342

VL - 44

SP - 135

EP - 158

JO - Acta medica academica

JF - Acta medica academica

SN - 1840-1848

IS - 2

ER -